e-Therapeutics, which uses informatics for discovering the safety and efficacy of new combinations or applications of existing medical compounds, has received a listing on the Alternative Investment Market (AIM) of the London Stock Exchange. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals
